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Abstract
Background—Gastroschisis and omphalocele are the most common anterior abdominal wall
defects affecting infants. There are few large cohort studies describing the frequency of associated
anomalies in infants with these 2 conditions. We describe associated anomalies and outcomes in
infants with these defects using a large, multi-center clinical database.
Methods—We identified all infants with gastroschisis or omphalocele from a prospectively
collected database of infants discharged from 348 neonatal intensive care units in North America
from 1997–2012. Maternal and patient demographic data, associated anomalies, and outcome data
were compared between infants with gastroschisis and omphalocele.
Results—A total of 4687 infants with gastroschisis and 1448 infants with omphalocele were
identified. Infants with omphalocele were more likely to be diagnosed with at least 1 other
anomaly compared with infants with gastroschisis (35% vs. 8%, p<0.001). Infants with
omphalocele were more likely to develop pulmonary hypertension compared with those with
gastroschisis (odds ratio [OR] 7.78; 95% confidence interval 5.81, 10.41) and had higher overall
mortality (OR 6.81 [5.33, 8.71]).
Conclusion—Infants with omphalocele were more likely to have other anomalies, be diagnosed
with pulmonary hypertension, and have higher mortality than infants with gastroschisis.
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Gastroschisis and omphalocele are the most common anterior abdominal wall defects in
infants, with estimated incidences of 1:4000 live-births for omphalocele and 1:12,000 live-
births for gastroschisis [1,2]. Gastroschisis is an abdominal wall defect in which the small
intestine, and occasionally the stomach or colon, is outside of the body without a
membranous protective sac [3]. Omphalocele is a midline abdominal wall defect in which a
thin membrane surrounds the protruding organs that can include small intestine, liver,
bladder, spleen, stomach, uterus, and ovaries [4].
Gastroschisis is associated with environmental factors such as teratogens, poor prenatal care,
maternal infections, and younger maternal age [3]. Although intestinal atresias are found in
as many as 28% of infants, non-intestinal anomalies are reported to be rare [4,5]. Infants
with omphalocele have a >50% risk of having a genetic anomaly, and this defect is
described in association with a number of genetic syndromes including trisomy 13, 18, and
21, and Beckwith-Wiedemann syndrome [4]. Non-intestinal anomalies, including cardiac
defects and pulmonary hypoplasia, are reported in up to 24% of infants with omphalocele
[6].
Associated anomalies and clinical outcomes in both conditions have been described in
single-center studies [7–10]. These studies suggest that the overall survival of infants with
gastroschisis is 92–96% and that their prognosis is determined by the degree of injury to the
bowel, severity of illness in the first week of life, and the immediate post-operative recovery
[10,11]. Mortality in infants with omphalocele is higher (20%) and may be related to the
presence or absence of other anomalies including intestinal atresia, cardiac defects, or
pulmonary hypoplasia [4,12].
We sought to describe anomalies and outcomes associated with gastroschisis and




We evaluated data from all infants diagnosed with either gastroschisis or omphalocele
discharged from 348 neonatal intensive care units (NICUs) in North America managed by
the Pediatrix Medical Group from 1997–2012. Data are entered into the database using a
computer-assisted tool that generates clinical notes. We collected both maternal and infant
data including: gestational age (GA), birth weight, mode of delivery, concomitant diagnoses,
Apgar score at 5 minutes, sex, race, age in days at first feeding, mechanical ventilation,
medication use, total length of hospitalization, and mortality at discharge.
2.2. Definitions
Anomalies, including gastroschisis and omphalocele, were diagnosed by the treating
neonatologists at each site during the normal clinical care of the infant. We defined major
Corey et al. Page 2






















congenital anomaly as an anomaly presenting at birth that was any of the following: lethal,
life-shortening, life-threatening, requiring major surgery, or affecting the infant’s quality of
life in a significant way [13,14]. We classified anomalies as cardiovascular, pulmonary,
neurologic, gastrointestinal, renal, hematologic, genetic, or other. We defined first day of
enteral feedings as the first day of life an infant received any type or amount of enteral
nutrition. We defined duration of mechanical ventilation as the total duration of mechanical
ventilation (conventional or high-frequency) during the hospitalization. We defined
pulmonary hypertension as any reported diagnosis of pulmonary hypertension or exposure to
inhaled nitric oxide (iNO) or sildenafil at any time during the infant’s hospitalization.
2.3. Statistical analysis
The unit of observation for this analysis was the infant. We used standard summary statistics
to describe infant characteristics and associated anomalies. We used chi square, Fisher’s
exact, and Wilcoxon rank sum tests where appropriate to compare demographic
characteristics or outcomes and the presence of associated anomalies between infants with
gastroschisis and those with omphalocele. We used multivariable linear and logistic
regression controlling for GA to evaluate the association between gastroschisis or
omphalocele and the outcomes of mortality, length of mechanical ventilation, length of
hospitalization, days to first enteral feeding, and diagnosis of pulmonary hypertension. We
plotted survival probabilities using the Kaplan-Meier method.
We conducted all analyses using Stata 12.0 (College Station, TX) and considered a p<0.05
to be statistically significant. Permission to conduct this analysis was provided by the Duke
University Institutional Review Board.
3. Results
We identified 1448 infants with omphalocele and 4687 infants with gastroschisis (Table 1).
Infants with omphalocele had a higher median birth weight (2824 g [interquartile range:
2205, 3340] vs. 2370 g [2041, 2734], p<0.001) and GA (37 weeks [35, 39] vs. 36 weeks [35,
37], p<0.001) compared with infants with gastroschisis. Infants with omphalocele were less
likely to be premature (<37 weeks GA) compared to those with gastroschisis (582/1448
[40%] vs. 3049/4687 [65%], p<0.001).
The majority of infants did not have additional anomalies (5257/6135 [86%]). We identified
1282 anomalies in 878 infants. Of the 6135 infants, 257 (4%) had >1 anomaly. Infants with
omphalocele were more likely to be diagnosed with at least 1 other anomaly than those with
gastroschisis (513/1448 [35%] vs. 365/4687 [8%], p<0.001). This was true for all anomaly
categories (Table 2).
In infants with known status at hospital discharge, mortality was higher in those with
omphalocele vs. those with gastroschisis (191/1049 [18%] vs. 143/3287 [4%], p<0.001)
(Table 3 and Fig. 1). The median length of hospitalization for the entire cohort of survivors
was 31 days (interquartile range: 22, 50 days). Among survivors, median length of
hospitalization was shorter for infants with omphalocele than for those with gastroschisis
(17 days [9, 36] vs. 33 days [24, 52], p<0.001). Infants with omphalocele who survived to
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hospital discharge were started on their first feeds at an earlier postnatal age (median 6 days
[3, 10] vs. 15 days [11, 21], p<0.001) and had a shorter duration of mechanical ventilation
(median 2 days [0, 5] vs. 4 days [2, 8], p<0.001) compared with infants with gastroschisis.
A total of 195 infants were diagnosed with pulmonary hypertension (Table 3). Infants with
omphalocele were more frequently diagnosed with pulmonary hypertension (134/1448 [9%]
vs. 61/4687 [1 %], p<0.001) and more frequently received pulmonary vasodilating agents
such as iNO (57/1448 [4%] vs. 33/4687 [1%], p<0.001) or sildenafil (10/1448 [1%] vs.
0/4687 [<0%], p<0.001) than infants with gastroschisis (Table 3). For infants with known
status at hospital discharge, mortality was higher in those with evidence of pulmonary
hypertension (diagnosis of pulmonary hypertension or treatment with sildenafil or iNO)
compared to those without (68/173 [20%] vs. 266/4703 [6%], p<0.001). Infants with
omphalocele and evidence of pulmonary hypertension had higher mortality compared with
those with gastroschisis and evidence of pulmonary hypertension (51/113 [45%] vs. 17/60
[28%], p=0.03).
4. Discussion
We described associated anomalies and short-term clinical outcomes of a large cohort of
infants with omphalocele or gastroschisis. Similar to prior reports, we observed that infants
with omphalocele were more frequently diagnosed with associated anomalies and that
mortality was higher in infants with omphalocele compared with those with gastroschisis. In
addition, we found that, among survivors, length of hospitalization was significantly longer
for infants with gastroschisis compared with those with omphalocele. Lastly, infants with
omphalocele were more likely to be diagnosed with pulmonary hypertension.
There is a known association between genetic disease and omphalocele. Several case reports
have described multiple members within a family being affected with omphalocele [15– 17].
In a single-center study of abdominal wall defects diagnosed in utero, chromosomal
abnormalities were found by karyotype in 8/29 (28%) fetuses with omphalocele [18]. We
observed a somewhat lower proportion of genetic syndromes in our larger cohort of infants
with omphalocele (15%) but found that infants who were diagnosed with omphalocele were
>10 times more likely to have genetic disease, including Beckwith-Wiedemann syndrome
and trisomies 13 and 18, compared with infants diagnosed with gastroschisis. Infants with
omphalocele also had a significantly higher likelihood of having non-intestinal
manifestations of disease, with the cardiac, renal, pulmonary, and neurologic systems being
affected. This observation is likely related to the higher rate of multi-organ systems
involvement in those with genetic syndromes.
Despite the higher prevalence of anomalies in infants with omphalocele, the proportion of
infants with gastroschisis diagnosed with at least 1 anomaly was significant at 365/4687
(8%). This proportion is comparable to that reported from the National Inpatient Sample and
Kids’ Inpatient Database, where a total of 4344 infants with gastroschisis were identified
using ICD-9 codes from 1988–2003, and complex gastroschisis cases, defined as the
presence of associated gastrointestinal anomalies, represented 11% of the entire cohort [5].
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In our cohort, infants with omphalocele were at significantly higher risk of having
pulmonary hypertension compared with those with gastroschisis. Pulmonary hypertension
and other chronic pulmonary complications have been previously described in several case
reports or case series of infants with omphalocele [7,19,20]. The etiology of pulmonary
hypertension in these infants is likely multifactorial. Pulmonary hypoplasia is the most
commonly described etiology of pulmonary hypertension found on autopsy in 14/27 infants
with giant omphalocele [19]. Alveolar capillary dysplasia has been suggested as the etiology
of pulmonary hypertension in another case [19]. Due to the association with congenital heart
disease, pulmonary hypertension may also be related to pulmonary over-circulation from left
to right shunts or structural abnormalities of the pulmonary arteries, though this is likely to
be a later finding [21].
We found that mortality in infants with omphalocele was considerably higher than in those
with gastroschisis. This finding is consistent with surgical reports of mortality in
gastroschisis being as low as 4%, significantly lower than for infants with omphalocele (8–
33%) [22]. In our series, mortality was highest for infants with omphalocele diagnosed with
pulmonary hypertension (45%)—considerably higher than mortality in all infants with
omphalocele (18%) and in infants with gastroschisis diagnosed with pulmonary
hypertension (28%).
Survivors with gastroschisis had a longer length of hospitalization compared with survivors
with omphalocele. While our study does not allow us to identify the exact reason for
prolonged hospitalization, the earlier initiation of enteral feeds in infants with omphalocele
may play a role. However, additional factors such as gastrointestinal dysmotility are known
to significantly affect time to full enteral nutrition and likely play a significant role in timing
of feeding initiation [4]. Trials of prokinetic agents have yielded mixed results, with duration
to full enteral nutrition after gastroschisis repair reaching almost 1 month [23,24]. In a study
of infants with gastroschisis or omphalocele identified in the same database from 1997–
2007, the relative proportion of total infant hospital days for patients with gastroschisis was
found to be increasing over time, while that for patients with omphalocele remained constant
[25]. The authors postulated that improved survival in infants with gastroschisis was
associated with a higher rate of medical complexity of those survivors, which led to
prolonged hospitalization.
Limitations of our study include those of any observational analysis, such as selection bias
and potential confounders. We recognize that some malformations observed and corrected at
the time of surgery may be underreported. For example, malrotation has been reported to
occur in 8–9% of cases of gastroschisis and omphalocele and was reported in only 1% of our
cohort [26]. We were not able to describe the size of the abdominal wall defects or the
extent of involvement of intra-abdominal organs in the defects. Further, we did not have
data available to assess the severity of cardiac, renal, pulmonary, neurologic, or genetic
diagnoses nor did we have data regarding the degree of pulmonary hypertension as assessed
by echo-Doppler or invasive measurements. We were therefore unable to adjust our analysis
for the severity of an associated anomaly including pulmonary hypertension. Our analysis of
pharmacologic therapy for pulmonary hypertension was further limited by the lack of
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information on medication dosing. Lastly, we did not have data on enteral feeding volume to
describe differences in volume of enteral feeding and time to full enteral feeding.
In conclusion, this study, which used a large multi-center NICU database, demonstrated that
infants with omphalocele had higher rates of genetic syndromes and extra-intestinal
manifestations of disease, similar to previous smaller studies. In addition, we demonstrated
that pulmonary hypertension was more frequently diagnosed in infants with omphalocele
compared with those with gastroschisis. While the etiology of the pulmonary hypertension is
likely multi-factorial, this is important information for those caring for these high-risk
patients in terms of antenatal and preoperative counseling and perioperative management. In
addition, these identified high-risk patients may be targeted for future clinical trials and
interventions to reduce pulmonary hypertension.
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• Gastroschisis and omphalocele are the most common anterior abdominal wall
defects affecting infants.
• In our study, infants with omphalocele were more likely to have other anomalies
and have higher mortality than infants with gastroschisis.
• We also found that pulmonary hypertension was more frequently diagnosed in
infants with omphalocele compared with those with gastroschisis.
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Kaplan-Meier curve demonstrating increased risk of mortality in infants with omphalocele
compared with infants with gastroschisis.
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<1000 34 (2%) 36 (1%)
1000–1499 80 (6%) 158 (3%)
1500–2499 381 (26%) 2574 (55%)
2500–3499 678 (47%) 1786 (38%)
≥3500 269 (19%) 126 (3%)
Gestational age (weeks)
<25 18 (1%) 10 (<1%)
26–28 31 (2%) 33 (1%)
29–32 129 (9%) 276 (6%)
33–36 404 (28%) 2730 (58%)
≥37 866 (60%) 1637 (35%)
Male 770 (54%) 2446 (52%)
Race/ethnicity
White 789 (57%) 2497 (56%)
Black 259 (19%) 392 (9%)
Hispanic 261 (19%) 1334 (30%)
Other 78 (6%) 253 (6%)
Inborn 1201 (84%) 4188 (89%)
Cesarean section 999 (70%) 3170 (69%)
5-minute Apgar
0–3 42 (3%) 59 (1%)
4–6 126 (9%) 207 (5%)
7–10 1247 (88%) 4320 (94%)





























Cardiac 162 (11%) 35 (1%)
Pulmonary valve stenosis 21 (2%) 9 (<1%)
Tetralogy of Fallot 25 (2%) 0 (0%)
Coarctation of the aorta 16 (1%) 6 (<1%)
Atrioventricular canal defect 16 (1%) 1 (<1%)
Double-outlet right ventricle 16 (1%) 0 (0%)
Gastrointestinal 98 (7%) 216 (5%)
Malrotation 20 (1%) 39 (1%)
Ileal atresia 11 (1%) 50 (1%)
Imperforate anus 49 (3%) 1 (<1%)
Bowel atresia 2 (<1%) 38 (1%)
Jejunal atresia 2 (<1%) 37 (1%)
Neurologic 58 (4%) 35 (1%)
Meningomyelocele 27 (2%) 5 (<1%)
Hydrocephalus 15 (1%) 12 (<1%)
Dandy Walker malformation 9 (1%) 2 (<1%)
Holoprosencephaly 3 (<1%) 4 (<1%)
Septum pellucidum atresia 0 (0%) 6 (<1%)
Pulmonary 49 (3%) 14 (<1%)
Pulmonary hypoplasia 50 (3%) 11 (<1%)
Pulmonary sequestration 1 (<1%) 1 (<1%)
Robin sequence 0 (0%) 1 (<1%)
Congenital lung cyst 0 (0%) 1 (<1%)
Larynx anomaly 1 (0%) 0 (0%)
Genetic 220 (15%) 51 (1%)
Beckwith-Wiedemann syndrome 84 (6%) 0 (<1%)
Chromosomal abnormality 44 (3%) 16 (<1%)
Trisomy 13 37 (3%) 1 (<1%)
Trisomy 18 35 (2%) 1 (<1%)
Trisomy 21 15 (1%) 2 (<1%)
Renal 80 (6%) 23 (1%)
Exstrophy of bladder 48 (3%) 8 (<1%)
Ambiguous genitalia 30 (2%) 3 (<1%)
Multicystic kidney 6 (<1%) 5 (<1%)
Dysplastic kidney 5 (<1%) 2 (<1%)
Obstructive uropathy 4 (<1%) 3 (<1%)
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Death 191 (18%) 143 (4%) 6.81 (5.33, 8.71)
Pulmonary hypertension 147 (10%) 70 (2%) 7.78 (5.81, 10.41)
Pulmonary hypertension diagnosis 134 (9%) 61 (1%) 9.04 (5.90, 10.96)
Inhaled nitric oxide 57 (4%) 33 (1%) 5.98 (3.88, 9.23)
Sildenafil 10 (1%) 0 (0%) N/A
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